American Battery Technology reports Q4 results
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
In Healthcare ETFs, Is iShares Pharma a Better Buy Than VanEck Biotech?
VanEck's concentrated 25-stock biotech play offers higher volatility, while iShares' broader pharma exposure delivered a 1.4% dividend yield and lower drawdown risk.
- iShares Pharma (IHE) focuses on established pharmaceutical companies
- VanEck Biotech (BBH) targets high-growth biotechnology firms
- BBH's beta is higher than IHE, indicating more volatility
Bond markets rattle economy, sparking controversial buyback
Welcome to The Hill's Business & Economy newsletter {beacon} Business & Economy Business & Economy The Big Story Bond markets rattle economy, sparking controversial buyback The U.S.
Even if all foreigners leave, South Africa’s problems will remain – Dr Yamson blames state failure
Economist and Board Chairman of MTN Ghana, Dr Ishmael Yamson, has blamed what he describes as state failure for South Africa’s economic difficulties.
